Jeremy D. Burgess

Affiliations: 
2016- Neuroscience Mayo Clinic Florida 
Google:
"Jeremy Burgess"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Burgess JD, Amerna D, Norton ES, et al. (2023) A mutant methionyl-tRNA synthetase-based toolkit to assess induced-mesenchymal stromal cell secretome in mixed-culture disease models. Stem Cell Research & Therapy. 14: 289
Fagen SJ, Burgess JD, Lim MJ, et al. (2023) Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression. Frontiers in Aging Neuroscience. 15: 1179086
Burgess JD, Amerna D, Norton ES, et al. (2023) A Mutant Methionyl-tRNA Synthetase-Based toolkit to assess induced-Mesenchymal Stromal Cell secretome in mixed-culture disease models. Research Square
Jin Y, Li F, Sonoustoun B, et al. (2022) APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology. Acta Neuropathologica
Faroqi AH, Lim MJ, Kee EC, et al. (2020) In vivo detection of extracellular ATP in a mouse model of traumatic brain injury. Journal of Neurotrauma
Park JH, Burgess JD, Faroqi AH, et al. (2020) Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway. Molecular Neurodegeneration. 15: 5
Delenclos M, Burgess JD, Lamprokostopoulou A, et al. (2019) Cellular models of alpha-synuclein toxicity and aggregation. Journal of Neurochemistry
Sims R, van der Lee SJ, Naj AC, et al. (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics
See more...